Erweiterte Suche

Gegenwärtig ist Jeremiah Alphonsus O'Callaghan Chairman für JBS SA und Co-Geschäftsführer bei JBS Investments II GmbH sowie Investor Relations Officer bei JBS Foods International (beides Tochtergesellschaften von JBS SA). Er ist außerdem im Vorstand von JBS Investments UK Ltd. Er erwarb einen Bachelor-Abschluss am University College Cork.

Barbara S. Jeremiah ist designierte Vorsitzende von The Weir Group Plc. Außerdem ist sie Mitglied der University of Virginia und im Vorstand von 6 weiteren Unternehmen. In der Vergangenheit war sie Vorsitzende von Boart Longyear Ltd. und Executive Vice President bei Alcoa Corp. sowie Executive Vice President-Corporate Development bei Alcoa, Inc. Sie erwarb einen Bachelor-Abschluss an der Brown University und einen Master-Abschluss an der University of Virginia School of Law.

Derzeit ist Jeremiah Brazeau Chief Technology Officer von Twilio, Inc. Zuvor hatte er die Position des Senior Vice President & Distinguished Architect bei salesforce.com, inc. inne. Er erhielt einen Undergraduate-Abschluss und einen Graduate-Abschluss vom Rochester Institute of Technology und einen Graduate-Abschluss von der Northeastern University.

Alphonsus Moniz worked as a Portfolio Manager at P.
Schoenfeld Asset Management LP from 2017 to 2019 and as a Partner & Portfolio Manager at Fore Research & Management LP from 2003 to 2017.
He holds a graduate degree from Boston College, an MBA from Cochin University of Science & Technology, and an undergraduate degree from Visvesvaraya College of Engineering.

Alphonsus Chua is currently the Managing Director at GB Chemicals Pte Ltd.
where he has been working since 1996.
Prior to this, he was the Managing Director at AP Oil International Ltd.

Alphonsus Richard Monteiro has worked as a Director at Plant-Tech Industrial Services Ltd.
since 2000.

Alphonsus A.
Okoye is a member of the Chartered Insurance Institute of Nigeria and the Chartered Institute of Marketing of Nigeria.
He was previously the General Manager & Head-Eastern Operations at Guinea Insurance Plc.
He completed his undergraduate degree at the University of Port-Harcourt and his MBA at the University of Calabar.
Dr. Okoye's current job(s) are with the Chartered Insurance Institute of Nigeria and the Chartered Institute of Marketing of Nigeria, where he holds the title of Member.

Paul O’Callaghan currently works as a Director at Trinity Youth Services.

Mr. Shea O’Callaghan is a Research Associate at Mackie Research Capital Corp.

Michael P.
O'Callaghan worked as a Vice President at Rubenstein Partners LP from 2006 to 2010.

Mr. Eugene O'Callaghan is a Director at National Treasury Management Agency.
He joined the firm in 2005.
Mr. O'Callaghan was employed at Irish Life Investment Managers where he had been an Executive Director and Chief Operating Officer and had worked for fifteen years in a variety of investment management and business management roles.
Prior to that, he lived in New Zealand for five years where he worked in an investment bank and in a major accounting firm.
He graduated from University College Dublin and a Chartered Accountant.

James Dominic O’Callaghan is the founder of Eckersley O’Callaghan Ltd., where he holds the title of Senior Director since 2004.
He is currently working as Secretary & Director at Eckersley O'Callaghan Group Ltd.

James O'Callaghan has a current job as a Director at The Stable Group LLC.

Caroline Jaqueline Michele O'Callaghan worked as an Investment Director at Rathbones Investment Management Ltd.
from 2012 to 2016.

Michael O'Callaghan is an economist who currently works at The Economic & Social Research Institute.

Kevin O'Callaghan is currently working as a Director & Vice President at Metro Vancouver Regional Parks Foundation.

Norma O'Callaghan currently works at Trend Micro France SAS, as Co-Chief Executive Officer from 2010, TREND MICRO Deutschland GmbH, as Co-Managing Director, Trend Micro (UK) Ltd., as Director from 2018, and Trend Micro EMEA (GB) Ltd., as Director.

Scott O'Callaghan is an Independent Director at North Mountain Merger Corp.
He previously worked as a Managing Director at MidOcean US Advisor LP from 2009 to 2010, and as an Independent Director at South Mountain Merger Corp.
from 2020 to 2021.
He also held Principal positions at Drexel Burnham Lambert Real Estate Associates II, Deutsche Bank Investment Management, Inc., and Bankers Trust & Co. Additionally, he was Head-Leveraged Sales at Bank of America Corp.
in 2009.
O'Callaghan received his undergraduate degree from Brown University in 1986.

Mr. Jon O'Callaghan is a Managing Director at Image Resources NL.

Tim O'Callaghan has a current job as the Chief of Staff at Memorial Medical Center of West Michigan.

John F.
O’Callaghan is currently the EVP, Global Head-Field Marketing & Operations at Triton International Ltd.
Prior to this, he worked at Triton Container International Ltd.
for 22 years, where his last position was Senior VP-Europe & North America Subcontinent.
He obtained his undergraduate degree from Trinity College Dublin.

Michael O'Callaghan is currently a member of the Governors Board at the Business Council of British Columbia.

Matt E.
O'Callaghan worked as an Analyst at Mariner Investment Group LLC from 2000 to 2002.
He also worked as an Analyst at Pirate Capital LLC.
Later, he worked as a Senior Bank Loan Trader at Odeon Capital Group LLC from 2011 to 2015.
O'Callaghan received his undergraduate degree from the University of St. Thomas in 1999.

Brian O'Callaghan was the founder and had founded Biopartners GmbH in 2000, where he served as the President & Chief Executive Officer until 2004.
He is currently the Chief Executive Officer & Director at Deep Genomics, Inc. since 2023, Director at BIOCOM since 2013, Director at Century Club of San Diego, Independent Director at Bolt Biotherapeutics, Inc. since 2021, and Director at Petra Pharma Corp.
since 2017.
Mr. O'Callaghan has held former positions as the President, Chief Executive Officer & Director at Sangart, Inc. from 2008 to 2014, President, Chief Executive Officer & Director at Acucela, Inc. in 2013, Chief Executive Officer at Sonrgy, Inc. from 2015 to 2017, Chief Commercial Officer at NPS Pharmaceuticals, Inc. from 2007 to 2008, General Manager at Labcorp Drug Development, Inc., General Manager at Merck KGaA, GM-North American Transplantation & Immunology at Novartis Pharmaceuticals Corp.
from 2004 to 2006, and Chief Executive & Financial Officer at Kubota Pharmaceutical Holdings Co. Ltd.
Mr. O'Callaghan also served as a Director at Aquavit Pharmaceuticals, Inc., Intec Pharma Ltd., ObsEva SA from 2020 to 2023, and Decoy Biosystems, Inc., as well as an Independent Director at Indaptus Therapeutics, Inc. He holds an MBA from The HENLEY College.

Mr. Shannon O'Callaghan is an Analyst at UBS Securities LLC.
Mr. O'Callaghan was previously employed as a Managing Director by Nomura Securities International, Inc., an Analyst by Credit Agricole Securities (USA), Inc., Barclays Capital, Inc., and a Lehman Brothers, Inc. He received his undergraduate degree from Boston College, a graduate degree from Boston College and an MBA from Massachusetts Institute of Technology.

Bernie O'Callaghan has worked as a Board Member & Representative for Athletics Ireland and is currently employed by Athletics Northern Ireland as a Board Member & Representative.

Mr. Conor O'Callaghan is a Managing Director at BTIG LLC.
Prior to BTIG, Mr. Conor was the Head of Investment Banking and a Managing Director within Structured Products at Brownstone Investment Group.
Previously, Mr. O’Callaghan was a Managing Director at Nomura Securities, where he held several senior roles in both the Investment Banking and Global Markets divisions throughout his decade with the firm.
Earlier in his career, he held similar roles at Barclays, Clay Finlay and Credit Suisse.